LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EARNINGS FLASH H impact Sep 29, 2026, 12:39 PM UTC

AT&T Reiterates Fincl Outlook and Cap Allocation Plan Provided in 2Q Earnings Release >T

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

GLW T

Related stories

Carnival Logs Higher 3Q Profit, Revenue on Accelerating Demand By Connor HartCarnival reported higher profit and revenue in the latest quarter on the back of continued strong demand, even as oil prices remain elevated.The cruise line on Tuesda L impact | EARNINGS | Sep 29, 2026, 01:43 PM UTC Banco Santander approves 2026 interim cash dividend of €0.127 per share Santander approved a 2026 interim cash dividend of €0.127 ($0.144) per share, up 10% versus last year’s interim dividend. The total interim shareholder remuneration for 2026 result M impact | EARNINGS | Sep 29, 2026, 01:40 PM UTC Misitano & Stracuzzi posts H1 revenue of €36.5 million and EBITDA €1.2 million Reuters cites Misitano & Stracuzzi SPA reporting H1 revenue of €36.5 million and H1 EBITDA of €1.2 million for Sept 29. M impact | EARNINGS | Sep 29, 2026, 01:35 PM UTC SmartStop Self REIT Sees FY26 Adj FFO $1.99-$2.05/Shr >SMA L impact | EARNINGS | Sep 29, 2026, 01:34 PM UTC Morgan Stanley on Earnings While the S&P 500 has made little headway since early June, the adjustment beneath the surface has been significant. As we have emphasized all year, earnings strength is doing the H impact | EARNINGS | Sep 29, 2026, 01:34 PM UTC Iovance Biotherapeutics Stock Gains After Raising FY Revenue Guidance on Demand for Melanoma Treatments By Kelly CloonanShares of Iovance Biotherapeutics rose after the company boosted its full-year revenue forecast, citing strong demand for two melanoma treatments.The stock gained 2 H impact | EARNINGS | Sep 29, 2026, 01:33 PM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.